Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8603104rdf:typepubmed:Citationlld:pubmed
pubmed-article:8603104lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:8603104lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:8603104lifeskim:mentionsumls-concept:C0007452lld:lifeskim
pubmed-article:8603104lifeskim:mentionsumls-concept:C0089793lld:lifeskim
pubmed-article:8603104lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:8603104lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:8603104lifeskim:mentionsumls-concept:C0006556lld:lifeskim
pubmed-article:8603104lifeskim:mentionsumls-concept:C1305923lld:lifeskim
pubmed-article:8603104lifeskim:mentionsumls-concept:C0728938lld:lifeskim
pubmed-article:8603104lifeskim:mentionsumls-concept:C1561491lld:lifeskim
pubmed-article:8603104pubmed:issue1lld:pubmed
pubmed-article:8603104pubmed:dateCreated1996-5-15lld:pubmed
pubmed-article:8603104pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8603104pubmed:abstractTextTwo phosphatidylinositol 4-kinase isozymes, type 3 and type 2, have been separated on hydroxylapatite after solubilizing bovine brain microsomes with Triton X-114. Employing a newly developed renaturation procedure following SDS-PAGE, we demonstrate that a 200 kDa polypeptide carries the enzyme activity of this type 3 isoform. Chromatography on hydroxylapatite, Heparin-Sepharose, Superdex 200 and finally SDS-PAGE results in an approximately 30,000-fold purification. Tryptic peptides generated from the 200 kDa polypeptide after SDS-PAGE have been sequenced and the obtained data have been used for constructing and synthesizing degenerated oligonucleotides. Polymerase chain reaction as well as screening of cDNA libraries allowed several clones to be isolated from which a 4.7 kb contiguous sequence can be built up. The open reading frame covers 4.4 kb with a 0.3 kb untranslated 3' end which yields a deduced amino acid sequence of 1,467 amino acids. The C-terminal part of ca. 300 amino acids represents the catalytic domain. Sequence alignment of this domain with the mammalian counterpart, the human type 2 phosphatidylinositol 4-kinase, the yeast kinases STT4 and PIK1, as well as with the catalytic domains of bovine, human, mouse and yeast phosphatidylinositol 3-kinases reveals a high degree of identity: 26 of these approximately 300 amino acids are invariable in all of these eight catalytic domains. Five motifs indicate nuclear localization and DNA binding properties of the enzyme. Two leucine zipper motifs (amino acids 358-386, 862-882) are detectable. Furthermore, a helix loop helix motif (amino acids 716-729) as well as two nuclear localization signals (amino acids 838-854, 345-349) indicate the presence of the type 3 isoform in the nucleus.lld:pubmed
pubmed-article:8603104pubmed:languageenglld:pubmed
pubmed-article:8603104pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8603104pubmed:citationSubsetIMlld:pubmed
pubmed-article:8603104pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8603104pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8603104pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8603104pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8603104pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8603104pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8603104pubmed:statusMEDLINElld:pubmed
pubmed-article:8603104pubmed:monthMarlld:pubmed
pubmed-article:8603104pubmed:issn0006-3002lld:pubmed
pubmed-article:8603104pubmed:authorpubmed-author:HeilmeyerL...lld:pubmed
pubmed-article:8603104pubmed:authorpubmed-author:SchmidtMMlld:pubmed
pubmed-article:8603104pubmed:authorpubmed-author:VarsányiMMlld:pubmed
pubmed-article:8603104pubmed:authorpubmed-author:VerebGGlld:pubmed
pubmed-article:8603104pubmed:authorpubmed-author:MeyerH EHElld:pubmed
pubmed-article:8603104pubmed:authorpubmed-author:KlixDDlld:pubmed
pubmed-article:8603104pubmed:authorpubmed-author:GehrmannTTlld:pubmed
pubmed-article:8603104pubmed:issnTypePrintlld:pubmed
pubmed-article:8603104pubmed:day27lld:pubmed
pubmed-article:8603104pubmed:volume1311lld:pubmed
pubmed-article:8603104pubmed:ownerNLMlld:pubmed
pubmed-article:8603104pubmed:authorsCompleteYlld:pubmed
pubmed-article:8603104pubmed:pagination53-63lld:pubmed
pubmed-article:8603104pubmed:dateRevised2007-12-11lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:meshHeadingpubmed-meshheading:8603104-...lld:pubmed
pubmed-article:8603104pubmed:year1996lld:pubmed
pubmed-article:8603104pubmed:articleTitleIdentification of a 200 kDa polypeptide as type 3 phosphatidylinositol 4-kinase from bovine brain by partial protein and cDNA sequencing.lld:pubmed
pubmed-article:8603104pubmed:affiliationRuhr-Universität Bochum, Institut für Physiologische Chemie, Abteilung für Biochemie Supramolekularer Systeme, Germany.lld:pubmed
pubmed-article:8603104pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8603104pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:282309entrezgene:pubmedpubmed-article:8603104lld:entrezgene